Atrial tachycardia and congestive heart failure: New insights from an old experimental model

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 8, 2004, Pages 933-935

  Stambler, Bruce S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; ELECTRIC POTENTIAL; GOAT; HEART RATE; HUMAN; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ANIMALS; ATRIAL NATRIURETIC FACTOR; DISEASE MODELS, ANIMAL; FEMALE; GOATS; HEART FAILURE, CONGESTIVE; TACHYCARDIA, ECTOPIC ATRIAL; TACHYCARDIA, VENTRICULAR;

EID: 4444229386     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04336.x     Document Type: Note

References (12)

1. Whipple GH, Sheffield LT, Woodman EG, Theophilas C, Friedman C: Reversible congestive heart failure due to rapid stimulation of the normal heart. Proc New Engl Cardiovasc Soc 1962;20:39-40.
2. Lenfant C: Report of the task force on research in heart failure. Circulation 1994;90:1118-1123.
3. Schoonderwoerd BA, Crijns HJ, Van Veldhuisen DJ, Boomsma F, Van den Berg MP, Bel KJ, Van Gelder IC: Atrial natriuretic peptides during experimental atrial tachycardia: Role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol 2004;15:927-932.
4. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Tieleman RG, Grandjean JG, Bel KJ, Allessie MA, Crijns HJ. Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: Role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol 2001;12:1404-1410.
5. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, Weyman AE: Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990;82:792-797.
6. Cheung BM, Kumana CR: Natriuretic peptides: Relevance in cardiovascular disease. JAMA 1998;280:1983-1984.
7. Clemo HF, Baumgarten CM, Ellenbogen KA, Stambler BS: Atrial natriuretic peptide and cardiac electrophysiology: Autonomic and direct effects. J Cardiovasc Electrophysiol 1996;7:149-162.
8. Dickstein K, Larsen AI, Bonarjee V, Thoresen M, Aarsland T, Hall C: Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol 1995;76:679-683.
9. Gottlieb SS, Kukin ML, Ahern D, Packer M: Prognostic importance of atrial natriuretic peptide in patients with congestive heart failure. J Am Coll Cardiol 1989;13:1534-1539.
10. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-663.
11. Mattioli AV, Bonatti S, Bonetti L, Borella P, Mattioli G: Left atrial size and function after spontaneous cardioversion of atrial fibrillation and their relation to N-terminal atrial natriuretic peptide. Am J Cardiol 2003;91:1478-1481.
12. Wozakowska-Kaplon B, Opolski G: Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol 2003;41:1716-1720.